170900.KS · 동아에스티

South Korea · RS rating 27 · As of 2026-10-14

Price34,200.00 KRW
1-day change+0.7%
RS rating (overall / 1M / 3M / 12M)27 / 35 / 34 / 37
StageBasing
Composite / Minervini / CANSLIM score23 / 19 / 27
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-66.9%
Sales growth Q/Q+10.3%
Distance from 52-week high+38.0%
Market cap (USD)$250.9M
Open South Korea in the interactive screener